While high-throughput small molecule screening is becoming a staple of many drug discovery engines, analogous technologies for antibody screening have been less numerous. Thus the development of a system for high-throughput screening of antibody-antigen interactions by researchers at the MRC Laboratory of Molecular Biology and colleagues could represent a new method for identifying both therapeutic targets and antibodies.

As published in Nature Biotechnology, MRC researchers created